Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $404.52 in the prior trading day, Humana Inc. (NYSE: HUM) closed at $361.61, down -10.61%. In other words, the price has decreased by -$10.61 from its previous closing price. On the day, 4.3 million shares were traded. HUM stock price reached its highest trading level at $380.89 during the session, while it also had its lowest trading level at $356.38.
Ratios:
Our goal is to gain a better understanding of HUM by taking a closer look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.82 whereas as Long-Term Debt/Eq ratio is at 0.77.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on June 26, 2024, initiated with a Overweight rating and assigned the stock a target price of $392.
On June 24, 2024, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $374.
BofA Securities Downgraded its Buy to Neutral on April 02, 2024, whereas the target price for the stock was revised from $470 to $342.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 20 ’24 when Mesquita Jorge S. bought 545 shares for $367.09 per share. The transaction valued at 200,066 led to the insider holds 2,578 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUM now has a Market Capitalization of 43574366208 and an Enterprise Value of 39738916864. As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.50, and their Forward P/E ratio for the next fiscal year is 17.86. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 13.33. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.40 while its Price-to-Book (P/B) ratio in mrq is 2.70. Its current Enterprise Value per Revenue stands at 0.364 whereas that against EBITDA is 8.886.
Stock Price History:
Over the past 52 weeks, HUM has reached a high of $530.54, while it has fallen to a 52-week low of $298.61. The 50-Day Moving Average of the stock is -1.60%, while the 200-Day Moving Average is calculated to be -9.09%.
Shares Statistics:
The stock has traded on average 1.39M shares per day over the past 3-months and 1484470 shares per day over the last 10 days, according to various share statistics. A total of 122.22M shares are outstanding, with a floating share count of 120.18M. Insiders hold about 0.27% of the company’s shares, while institutions hold 96.83% stake in the company. Shares short for HUM as of 1721001600 were 2571116 with a Short Ratio of 1.85, compared to 1718323200 on 3186990. Therefore, it implies a Short% of Shares Outstanding of 2571116 and a Short% of Float of 2.1399999999999997.
Dividends & Splits
In the trailing 12 months, HUM’s forward annual dividend rate was 3.54, compared to 3.54 this year. Against a Trailing Annual Dividend Yield of 0.008751113The stock’s 5-year Average Dividend Yield is 0.68.
